Vertex's Triple CF Combo Gets EU Approval Nod; Rejection For Daiichi Sankyo

EU approval is likely for the eight medicines that got the thumbs up this week from the European Medicines Agency's drug evaluation committee, the CHMP. The panel held fire on one product it had been considering and also issued its first rejection of 2020.

 hands holding jigsaw puzzles, business to business, business matching concept
Kaftrio is set to become Europe's first triple combination therapy for CF • Source: Shutterstock

More from Product Reviews

More from Pink Sheet